Abstract
The hormone receptor concentrations in tumour tissues from 20 renal carcinoma patients were determined before postoperative medroxyprogesterone acetate (MPA) therapy was started. Except for glucocorticoid receptors, the concentrations were either not measureable or were extremely low. The question is whether MPA therapy, solely on the strength of its character as a general roborant, is still useful in the treatment of renal tumours, even when it fails to exercise primary influence because of the absence of suitable receptors. None of the 20 patients was treated with MPA.
Similar content being viewed by others
References
Bloom, H. J. G.: Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer.Br. J. Cancer, 25, 250 (1971).
Bojar, H.: Steroidrezeptoren. In: K.-G. von Boroviczény, R. Merten, U. P. Merten (eds): Qualitätssicherung im medizinischen Laboratorium. Springer Verlag, Berlin 1987, p. 458.
Bojar, H.: Hormone responsiveness of renal cancer.World J. Urol., 2, 98 (1984).
Concolino, G., di Silvero, F., Marocchi, A., Bracci, U.: Renal cancer steroid receptors: biochemical basis for endocrine therapy.Eur. Urol., 5, 90 (1979).
Concolino, G., Marocchi, A., Conti, D., Tenaglia, R., Di Silvero, F., Bracci, U.: Human renal cell carcinoma as a hormone-dependent tumor.Cancer Res., 38, 4340 (1978).
Di Fronzo, G., Ronchi, E., Bertuzzi, A., Vezzoni, P., Pizzocaro, G.: Estrogen receptors in renal carcinoma.Eur. Urol., 6, 307 (1980).
Kopper, L., Magyarossy, E., Nagy, P., Lapis, K., Számel, J., Eckhardt, S. Csata, S., Wabrosch, G., Répássy, D.: Renal cell carcinoma—xenotransplantation into immune suppressed mice.Oncology, 41, 1924 (1984).
Nakano, E., Yasaharu, T., Hideki, F., Minoru, M., Masao, O., Thoshihiko, K. Burizo, S., Minato, T., Takao, S.: Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy.J. Urol., 132, 240 (1984).
Pearson, J., Friedmann, M. A., Hoffmann, P. G.: Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy.Cancer Chemother. Pharmacol., 6, 151 (1981).
Orovan, W. L., Ryan, E. D.: Estrogen and progesterone binding sites in renal cell carcinoma.Urology, 34, 65 (1989).
Servadio, C.: Steroid receptors in renal cell carcinoma.J. Urol., 131, 227 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Romics, I., Rüssel, C. & Bach, D. Experience with hormone receptors in renal cancer. International Urology and Nephrology 22, 507–512 (1990). https://doi.org/10.1007/BF02549737
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549737